What is Zacks Research’s Estimate for TSE:BHC Q4 Earnings?

Bausch Health Companies Inc. (TSE:BHC) – Stock analysts at Zacks Research reduced their Q4 2025 earnings per share (EPS) estimates for shares of Bausch Health Companies in a report issued on Tuesday, December 23rd. Zacks Research analyst Team now forecasts that the company will post earnings per share of $1.63 for the quarter, down from their prior forecast of $1.66. The consensus estimate for Bausch Health Companies’ current full-year earnings is $5.55 per share. Zacks Research also issued estimates for Bausch Health Companies’ Q1 2026 earnings at $1.13 EPS, Q3 2026 earnings at $1.50 EPS, FY2026 earnings at $5.37 EPS, Q2 2027 earnings at $1.32 EPS, Q3 2027 earnings at $1.42 EPS and FY2027 earnings at $5.30 EPS.

Other research analysts also recently issued research reports about the stock. Barclays upgraded shares of Bausch Health Companies to a “hold” rating in a research note on Monday, December 8th. Raymond James Financial upgraded Bausch Health Companies to a “hold” rating in a research note on Monday, December 15th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, Bausch Health Companies currently has an average rating of “Hold”.

Bausch Health Companies Stock Performance

Shares of BHC stock opened at C$9.84 on Thursday. The company has a market capitalization of C$3.65 billion, a price-to-earnings ratio of 10.14, a price-to-earnings-growth ratio of 0.21 and a beta of 0.69. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. Bausch Health Companies has a one year low of C$5.91 and a one year high of C$11.97. The company’s 50-day moving average is C$9.19 and its 200 day moving average is C$9.16.

Bausch Health Companies (TSE:BHC) last released its earnings results on Wednesday, October 29th. The company reported C$0.48 EPS for the quarter. The firm had revenue of C$2.68 billion for the quarter. Bausch Health Companies had a positive return on equity of 15.87% and a negative net margin of 1.88%.

Bausch Health Companies Company Profile

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries.